OMNIQ Corp. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data OMNIQ Corp. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	60	54.5	56.2	57.2	55.2	78.3	101	81.2	34.9	33
Cost of revenue	48	43.1	43.1	43.2	44.3	61.6	78.7	65.5	29.3	23.9
Gross profit	12.1	11.4	13.1	14	10.9	16.7	22.1	15.7	5.63	9.04
Research and development				1.06	1.81	1.87	1.83	2.15	1.85	2.02
Selling, general and administrative				13.7	15.8	21.9	27.7	23	9.14	9.82
General and administrative	2.33	1.86	2.47	2.67
Operating expenses	13.3	12.2	16.1	16.9	19.9	27.1	31.7	41.9	12.3	12.9
Operating income	-1.19	-0.88	-3.02	-2.86	-8.98	-10.5	-9.55	-26.2	-6.62	-3.85
Interest expense	0.73	0.08	0.12	2.56	2.63	2.52	3.5	3.3	1.06	1.18
Other non-operating income	0.01	0.03	-2.7	-2.58	-2.52	-2.51	-4.1	-3.88	-1.55	3.31
Pre-tax income					-11.5	-13	-13.6	-30.1	-8.17	-0.53
Income tax	-1.07		0.51	-0.01	0.01	0.16	-0.04	-0.64	-0.7	0.5
Income from continuing operations	-7.49	-2.43
Net income to minority interests						0.22	0.07
Net income	-14.3	-2.43	-5.22	-5.46	-11.5	-13.4	-13.7	-29.4	-10	-0.14
EBITDA	0.6	0.88	-1.18	-0.71	-6.69	-7.07	-7.43	-24.1	-5.33	-2.69
EPS, basic	-7.93	-1.19	-2.18	-1.37	-2.49	-2.20	-1.82	-3.50	-0.94	-0.01
EPS, diluted	-7.93	-1.19	-2.18	-1.37	-2.66	-2.20	-1.82	-3.50	-0.94	-0.01
Shares, basic (weighted)	1.81	1.81	2.48	3.89	4.32	6.08	7.58	8.41	10.7	11.2
Shares, diluted (weighted)	1.81	1.81	2.48	3.89	4.32	6.08	7.58	8.41	10.7	11.2

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	0.29	0.03	0.38	1.62	5.13	7.09	1.31	1.68	2.35	0.68
Receivables	10.6	6.39	12.3	6.69	9.66	27.1	23.9	18.7	20.9	9.54
Inventory	0.53	0.44	1.8	1.89	1.51	6.96	8.73	6.03	7.41	3.41
Other current assets	0.77	0.13	0.08	0.07	0.01	0.01	0.47	0.03	0.1	0.05
Total current assets	13.1	7.46	14.7	10.6	17	43.2	35.7	27.4	31.9	14.5
Property, plant and equipment	0.14	0.09	0.39	0.46	0.29	1.13	1.09	1.07	0.72	0.53
Lease right-of-use assets			0.24	0.13	0.08	3.56	2.3	1.86	1.08	1.66
Goodwill	10.1	10.1	13.9	13.9	14.7	16.5	16.5	1.79	2.92	3.34
Intangible assets	19.5	17.8	24.5	22.5	21.2	25.8	7.47	5.66	4.71	4.25
Other non-current assets								1.76	2.28	1.95
Total assets	32.8	26.1	40.1	34.5	38.7	75.1	64.8	39.5	43.6	26.2
Accounts payable	10.6	13.2	17.5	18.7	26.8	45.6	53.7	56.7	66.1	11.2
Deferred revenue	0.88	0.76
Short-term debt	2.39	1.5								3.14
Total current liabilities	28.4	22.9	35.2	30.8	41.8	66.1	73.5	72.7	86.3	27.7
Long-term debt	0.13	0.13	0.13	0.14	0	2.65	0.06	0.27	0.23
Lease liabilities				0.08	0.05	2.27	1.4	1.01	0.35	1.24
Other non-current liabilities	0.33	0.44	0.61	0.38	1.15	1.42	0.27	0.45	0.49	0.72
Total liabilities	47.6	27.3	37.9	32.6	43.7	72.8	75.3	74.5	87.5	38.9
Total debt					1.12
Paid-in capital	18.3	34.5	44.9	46.9	51.8	70.6	73.7	78.3	78.7	114
Retained earnings	-32.9	-35.6	-39.8	-45.1	-56.7	-70.6	-84.5	-114	-124	-124
Treasury stock	-0.23	-0.23	-0.23
Other comprehensive income			0	-0	-0.17	-0.15	0.21	0.55	1.29	-2.26
Shareholders' equity	-14.8	-1.25	2.52	1.81	-5.04	-0.1	-10.5	-35	-43.9	-12.7
Minority interests						2.4
Total equity	-14.8	-1.25	2.52	1.81	-5.04	2.3	-10.5	-35	-43.9	-12.7
Total liabilities and equity	32.8	26.1	40.1	34.5	38.7	75.1	64.8	39.5	43.6	26.2
Shares outstanding	1.77	1.86	3.6	3.96	4.68	7.46	7.71	10.7	10.7	15.1

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-14.3	-2.43	-5.22	-5.46	-11.5	-13.1	-13.6	-29.4	-10	-0.14
Depreciation and amortization	1.79	1.76	1.84	2.15	2.29	3.41	2.12	2.1	1.29	1.16
Stock-based compensation	0.37	0.75	2.39	1.27	2.01	2.55	3.17	1.96	0.36	0.08
Deferred income tax	-0.77		0.55				0.03	0.22	0.88
Change in receivables	-2.69	4.2	-5.85	5.57	-2.95	-3.29	1.47	4.95	-2.68	7.91
Change in inventory	-0.06	-0.03	-0.43	-0.18	0.38	-0.54	-2.49	2.4	-1.43	3.5
Change in payables	8.88	2.67	8.11	2.01	8.06	8.35	10.8	2.73	9.46	-2.84
Cash from operations	5.65	7.49	2.7	4.26	-0.42	-3.18	1.2	0.17	2.37	7.5
Capital expenditures		-0.02	-0.03	-0.13	-0	-0.3	-0.45	-0.48	-0.04	-0.69
Acquisitions			0.02			-4.99
Purchases of investments										-2.39
Cash from investing	0.58	-0.04	0.15	-0.25	0.09	-9.24	-4.15	-0.33	-0.03	-3.05
Debt repaid	-3.61	-6.35	-3.82	-3.37	-1.02	-4.61
Stock issued	0.02	0.03	0.01	3.77		13.3		2.41		0.94
Dividends paid						-0.31	-1.45
Cash from financing	-2.18	-7.72	-2.56	-2.77	3.43	14.5	-3.06	-0.05	-2.87	-1.73
Exchange rate effect			0.06
Net change in cash	-0.53	-0.26	0.29	1.24	3.1	2.06	-6.01	-0.21	-0.54	2.72
Free cash flow		7.47	2.67	4.12	-0.42	-3.47	0.75	-0.31	2.33	6.81
Interest paid	1.03	0.69	1.44	2.17	2.4	1.55	2.57	3.32	3.46	1.95
Income taxes paid	0.4	-0.02		0.05	0.2	0.15	0.07			0.5

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $0.09 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	26.8%	Gross profit / revenue.
Operating margin	-19.9%	Operating income / revenue.
EBITDA margin	-18.0%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-13.0%	Pre-tax income / revenue.
Net margin	-7.9%	Net income / revenue.
Operating cash flow margin	7.2%	Cash from operations / revenue.
Return on assets (ROA)	-10.1%	Net income / average total assets.
R&D / revenue	6.7%	Research and development expense / revenue.
SG&A / revenue	37.4%	Selling, general and administrative expense / revenue.
D&A / revenue	1.9%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-5.5%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-31.1%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-9.8%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	60.5%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-25.8%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-3.7%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	216.7%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	84.0%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow growth, 1y	192.8%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	108.4%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y	-39.9%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-26.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-7.5%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	4.8%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	13.9%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	21.0%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.47x	Current assets / current liabilities.
Quick ratio	0.32x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.04x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	159.3%	Total liabilities / total assets.
Interest coverage	-4.65x	Operating income / interest expense.
Working capital	-$15.2M	Current assets - current liabilities.
Goodwill and intangibles / assets	13.2%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$18.2M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.28x	Revenue / average total assets.
Fixed asset turnover	63.2x	Revenue / average property, plant and equipment.
Inventory turnover	7.80x	Cost of revenue / average inventory.
Days inventory	47 days	365 x average inventory / cost of revenue.
Receivables turnover	3.93x	Revenue / average receivables.
Days sales outstanding	93 days	365 x average receivables / revenue.
Days payables	162 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	-22 days	Days inventory + days sales outstanding - days payables.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.17	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$2.13	Revenue / diluted weighted shares.
Operating cash flow per share	$0.15	Cash from operations / diluted weighted shares.
Book value per share	-$0.98	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$1.20	Tangible book value / shares outstanding.
Cash per share	$0.07	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$1.4M	Share price x shares outstanding.
Enterprise value	$311.1K	Market cap + total debt - cash - short-term investments.
P/S	0.04x	Market cap / revenue.
P/OCF	0.60x	Market cap / cash from operations, when positive.
EV/Sales	0.01x	Enterprise value / revenue.
Earnings yield	-181.8%	Net income / market cap (the inverse of P/E).

What was OMNIQ Corp.'s revenue in fiscal 2025?

OMNIQ Corp. reported revenue of $33.0M for fiscal 2025, 5.5% lower than the year before.

Was OMNIQ Corp. profitable in fiscal 2025?

No. It reported a net loss of $137.0K.

How much free cash flow did OMNIQ Corp. generate in fiscal 2025?

Cash from operations of $7.5M minus capital expenditures of $690.0K left free cash flow of $6.8M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to OMNIQ Corp.